View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 28, 2020

Medtronic secures favourable decision in patent dispute

Medtronic has received a favourable decision from the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office in a dispute with Axonics Modulation Technologies.

Medtronic has received a favourable decision from the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office in a dispute with Axonics Modulation Technologies.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The companies were in a dispute over the intellectual property for Medtronic’s sacral neuromodulation device offerings after Medtronic filed a suit against Axonics for the infringement of seven patents last year.

In response, Inter Partes Review (IPR) was launched by Axonics on all seven patents.

However, the PTAB rejected without hearing the challenge to Medtronic’s US Patent No 9,463,324 (‘324 patent), which protects key technology related to implant recharging and temperature control.

The patent is vital in the infringement case pending against Axonics.

According to the company, the PTAB found there was no reasonable likelihood that any claims of the ‘324 patent are invalid. The decision by the board is final and cannot be appealed.

Medtronic Restorative Therapies Group Pelvic Health & Gastric Therapies business vice-president and general manager Brooke Story said: “Medtronic is pleased with the PTAB’s decision to uphold the most important of the patents challenged. Innovation is vital to our business and we will vigorously defend our IP Portfolio in this case.”

Meanwhile, the PTAB will launch full IPR proceedings in relation to the six additional patents in question. In those IPR proceedings, the PTAB will hear testimony and arguments from both sides.

The board is expected to issue a final decision regarding the patent dispute between Medtronic and Axonics within next 12 months.

In September last year, Axonics received the US Food and Drug Administration (FDA) approval for its rechargeable sacral neuromodulation (r-SNM) System to treat faecal incontinence.

The company obtained CE mark for its rechargeable sacral neuromodulation system (SNM) in 2016 to treat urinary and faecal dysfunction.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network